Status:
UNKNOWN
Effect of Type of Head Positioning on Retinal Displacement in Vitrectomy for Retinal Detachment
Lead Sponsor:
Unity Health Toronto
Conditions:
Retinal Detachment
Metamorphopsia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients may experience metamorphopsia, or image distortion, after having vitrectomy to repair their rhegmatogenous retinal detachments especially those with a detached macula. Retinal displacement, a...
Detailed Description
Rhegmatogenous retinal detachments (RRD) are a sight-threatening condition with an incidence of approximately 10 per 100 000 people. RRDs can be broadly classified into those with the macula still att...
Eligibility Criteria
Inclusion
- Age ≥ 18
- Diagnosis of primary rhegmatogenous retinal detachment needing pars plana vitrectomy with the detachment involving at least one of the temporal vascular arcades, which would allow retinal displacement to be detected on fundus autofluorescence photography
Exclusion
- Rhegmatogenous retinal detachment with an attached macula
- Proliferative retinopathy grade C or worst
- Prior vitrectomy for retinal detachment. Patients having had pneumatic retinopexy that failed to completely reattach the retina and therefore now needing vitrectomy are allowed into the study
- History of preoperative binocular diplopia
- Tamponade with silicone oil instead of gas
- Inability to maintain post operation head positioning
- Mental incapacity
Key Trial Info
Start Date :
August 26 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
324 Patients enrolled
Trial Details
Trial ID
NCT04035343
Start Date
August 26 2019
End Date
October 1 2024
Last Update
April 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, St. Michael's Hospital
Toronto, Ontario, Canada, M5C 2T2